Human adult stem cells from sweat glands (SGSCs) have great potential for regenerative therapies. It has already been shown in animal experiments that SGSCs promote skin wound healing, resulting in increased revascularization and faster closure of the wound. In the future, SGSCs will be made available for clinical use. For this an adaptation of the manufacturing and cultivation process according to GMP guidelines is necessary. In addition, further areas of application (for example biologization of implants) are to be tapped.